BIBR1532的固体分散:用于食道状癌的强效治疗药物
Xue-Juan Zhang1, Nai-Xuan Deng1, Huan-Qing Zhang1
1College of Pharmacy, Jinan University, Guangzhou 511443, Guangdong Province, China.
World journal of gastrointestinal oncology
|January 29, 2026
概括
固体分散技术提高了BIBR1532在食道状细胞癌 (ESCC) 治疗中的可溶性. 基甲基纤维素 (HPMC) 被确定为改善生物可用性的最佳载体.
科学领域:
- 在瘤学瘤学.
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
背景情况:
- BIBR1532是一种端粒酶抑制剂,有可能用于食道状细胞癌 (ESCC) 治疗.
- 它的临床应用受到水溶性差的阻碍.
- 端粒酶抑制会影响DNA损伤反应通路和端粒结合蛋白.
研究的目的:
- 为ESCC解决BIBR1532的临床翻译挑战.
- 确定一种最佳的药物输送策略,以克服BIBR1532的溶解性差.
- 评估固体分散 (SD) 技术作为一个潜在的解决方案.
主要方法:
- 使用PubChem衍生的简化分子输入线输入系统 (SMILES) 标识符进行系统分析.
- 人工智能驱动的FormulationDT平台对口服配方可行性的评估.
- 材料分析以确定最佳载体,重点是基甲基纤维素 (HPMC).
主要成果:
- 与基于脂质的配方相比,固体分散 (SD) 技术被认为是一种优越的溶解策略.
- 由于低湿度和高温稳定性,HPMC被确定为最佳载体.
- 基于HPMC的SD显著提高了BIBR1532的溶解性和生物可用性.
结论:
- 基于HPMC的固体分散是一种有前途的策略,可以提高BIBR1532在治疗ESCC中的疗效.
- 这种方法克服了BIBR1532的可溶性限制,使潜在的临床翻译成为可能.
- 对于BIBR1532配方,建议对SD制造进行进一步的试点研究.
相关概念视频
Molecular and Ionic Solids
20.0K
Crystalline solids are divided into four types: molecular, ionic, metallic, and covalent network based on the type of constituent units and their interparticle interactions.
Molecular Solids
Molecular crystalline solids, such as ice, sucrose (table sugar), and iodine, are solids that are composed of neutral molecules as their constituent units. These molecules are held together by weak intermolecular forces such as London dispersion forces, dipole-dipole interactions, or hydrogen bonds, which...
Molecular Solids
Molecular crystalline solids, such as ice, sucrose (table sugar), and iodine, are solids that are composed of neutral molecules as their constituent units. These molecules are held together by weak intermolecular forces such as London dispersion forces, dipole-dipole interactions, or hydrogen bonds, which...
20.0K
Network Covalent Solids
16.2K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.2K
Metallic Solids
20.6K
Metallic solids such as crystals of copper, aluminum, and iron are formed by metal atoms. The structure of metallic crystals is often described as a uniform distribution of atomic nuclei within a “sea” of delocalized electrons. The atoms within such a metallic solid are held together by a unique force known as metallic bonding that gives rise to many useful and varied bulk properties.
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
20.6K
Structures of Solids
17.7K
Solids in which the atoms, ions, or molecules are arranged in a definite repeating pattern are known as crystalline solids. Metals and ionic compounds typically form ordered, crystalline solids. A crystalline solid has a precise melting temperature because each atom or molecule of the same type is held in place with the same forces or energy. Amorphous solids or non-crystalline solids (or, sometimes, glasses) which lack an ordered internal structure and are randomly arranged. Substances that...
17.7K
Distribution and Dispersion
25.1K
To understand intra-specific interactions in populations, scientists measure the spatial arrangement of species individuals. This geographic arrangement is known as the species distribution or dispersion. Highly territorial species exhibit a uniform distribution pattern, in which individuals are spaced at relatively equal distances from one another. Species that are highly tied to particular resources, such as food or shelter, tend to concentrate around those resources, and thus exhibit a...
25.1K
Therapeutic Index
6.8K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K


